These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 2184127

  • 21. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
    Rybár I, Kriska M, Vavrecka A, Hyrdel R, Rovenský J.
    Cas Lek Cesk; 1999 Nov 15; 138(22):675-80. PubMed ID: 10746025
    [Abstract] [Full Text] [Related]

  • 22. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
    Koelz HR.
    Schweiz Rundsch Med Prax; 1994 Jun 21; 83(25-26):768-71. PubMed ID: 8029591
    [Abstract] [Full Text] [Related]

  • 23. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL, Walker AM, Bortnichak EA, Dreyer NA.
    Arch Intern Med; 1995 Jul 10; 155(13):1371-7. PubMed ID: 7794085
    [Abstract] [Full Text] [Related]

  • 24. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 10; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 25. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M, Svorcan P, Milanovic P, Antovic A, Milosevic D.
    Rom J Gastroenterol; 2005 Sep 10; 14(3):253-8. PubMed ID: 16200236
    [Abstract] [Full Text] [Related]

  • 26. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
    Ong TZ, Hawkey CJ, Ho KY.
    J Clin Gastroenterol; 2006 Oct 10; 40(9):795-800. PubMed ID: 17016134
    [Abstract] [Full Text] [Related]

  • 27. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 28. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 15; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 29. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A.
    Br J Hosp Med; 2003 Nov 15; 49(11):767-72. PubMed ID: 8101464
    [Abstract] [Full Text] [Related]

  • 30. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM.
    Rev Gastroenterol Disord; 2005 Nov 15; 5 Suppl 2():39-49. PubMed ID: 16369226
    [Abstract] [Full Text] [Related]

  • 31. [Corticosteroids, non-steroidal antirheumatic agents and the gastroduodenum].
    Börsch G.
    Z Rheumatol; 1984 Nov 15; 43(1):1-8. PubMed ID: 6608837
    [Abstract] [Full Text] [Related]

  • 32. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():67-72. PubMed ID: 15943850
    [Abstract] [Full Text] [Related]

  • 33. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Jun 15; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 34. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct 15; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 35. [NSAIDs induced gastroduodenal ulcer in the aged].
    Asaki S.
    Nihon Rinsho; 2002 Aug 15; 60(8):1527-32. PubMed ID: 12187746
    [Abstract] [Full Text] [Related]

  • 36. [Value of pepsinogen I in serum as a screening method for early detection of gastroduodenal lesions and follow-up in therapy with non-steroidal antirheumatic drugs].
    Kullich W, Pöllmann G, Zmerekar C, Klein G.
    Z Rheumatol; 1991 Aug 15; 50(1):39-45. PubMed ID: 2058321
    [Abstract] [Full Text] [Related]

  • 37. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR.
    Am J Med; 1998 Mar 30; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [Abstract] [Full Text] [Related]

  • 38. [Prevention of gastroduodenal disorders due to non-steroidal anti-inflammatory drugs].
    Hameeteman W, Dekker W.
    Ned Tijdschr Geneeskd; 1991 Apr 20; 135(16):723-4. PubMed ID: 2038401
    [No Abstract] [Full Text] [Related]

  • 39. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs.
    Loeb DS, Ahlquist DA, Talley NJ.
    Mayo Clin Proc; 1992 Apr 20; 67(4):354-64. PubMed ID: 1548951
    [Abstract] [Full Text] [Related]

  • 40. Nonsteroidal anti-inflammatory drugs and gastroduodenal injury.
    Venkat K, Brown MD, Barkin R.
    Am J Ther; 1998 Jul 20; 5(4):263-72. PubMed ID: 10099068
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.